Overview:
This pilot study evaluated the safety and efficacy of combining oxymetazoline hydrochloride (OXY) with mometasone furoate (MNS) nasal spray in adults with a ≥1-year history of moderate-to-severe nasal congestion that was unresponsive to corticosteroid monotherapy. The 20-day, randomized, double-blind, placebo-controlled trial compared MNS + OXY versus MNS + placebo in 23 patients.
The Takeaways:
-
Nasal congestion improvement: Patients receiving the OXY + MNS combination showed greater reductions in nasal congestion scores at all time points compared to those on MNS alone, though the difference did not reach statistical significance.
-
Activity-based quality of life (QOL): The combination group showed statistically significant improvement in activity-related QOL metrics—including daily activities, recreation, and sleep—with sleep improvements being the most consistent.
-
Tolerability: No cases of rhinitis medicamentosa or serious adverse effects were reported. Slightly more nasal erythema was observed with OXY, but there were no significant safety concerns.
-
Clinical implication: The study supports that adding oxymetazoline to corticosteroids may enhance decongestant response in patients with steroid-refractory symptoms, without introducing notable safety risks.
Why It Matters:
This study addresses a key unmet need: persistent nasal congestion that does not respond to corticosteroids alone. By combining a topical decongestant with a corticosteroid, clinicians can potentially offer faster and more robust relief—without the rebound concerns traditionally associated with oxymetazoline.
The Link to Allermi:
Allermi’s protocol mirrors the approach validated by this study: combining micro-dosed oxymetazoline with intranasal corticosteroids like mometasone in select patients. This evidence supports Allermi’s customizable spray model, especially for those whose congestion persists despite steroid use alone. The findings reinforce Allermi’s strategy of balancing fast symptom relief with long-term safety.
For more details, refer to the full study: Oxymetazoline Hydrochloride Combined With Mometasone Nasal Spray for Persistent Nasal Congestion
